Advertisement
Advertisement
February 15, 2016
Codman Neuro Launches Codman Enterprise 2 to Treat Wide-Necked Intracranial Aneurysms
February 16, 2016—Codman Neuro, part of the DePuy Synthes Companies of Johnson & Johnson, announced the launch of the Codman Enterprise 2 vascular reconstruction device, the latest generation of the company’s self-expanding stent and delivery system used to treat wide-necked intracranial aneurysms and to help maintain the position of endovascular coils during and after the procedure.
Codman Neuro advised that the Codman Enterprise and the Codman Enterprise 2 vascular reconstruction devices have been approved by the US Food and Drug Administration under a humanitarian device exemption in the United States only. The devices are authorized by United States federal law for use with embolic coils for the treatment of wide-necked, intracranial, saccular, or fusiform aneurysms arising from a parent vessel with a diameter of ≥ 2.5 mm and ≤ 4 mm. "Wide-necked" is defined as having a neck width ≥ 4 mm or a dome-to-neck ratio < 2.
According to the company, the new Codman Enterprise 2 system is designed to improve vessel wall conformability while maintaining a stable structure at the neck of an aneurysm. The device helps secure the placement of endovascular coils and maintains blood flow through the artery. In addition, the stent is more visible under fluoroscopy than the previous device and has a self-flushing introducer to facilitate ease of use.
The new device is being featured at the American Association of Neurological Surgeons/Congress of Neurological Surgeons Joint Cerebrovascular Annual Meeting held in conjunction with the Society for Neurointerventional Surgeons on February 15–16 in Los Angeles, California.
In the company’s press release, Donald Frei, MD, commented, “The precision, conformability, and occlusion that can be achieved when treating wide-necked aneurysms with the Codman Enterprise 2 system are excellent. It was easy to use and deploy and met all expectations for treatment. This is truly a next-generation stent that helps overcome the clinical challenges of treating wide-necked aneurysms.” Dr. Frei is a neurointerventional radiologist at Radiology Imaging Associates in Denver, Colorado.
Advertisement
Advertisement